Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Completed

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung scarring leading to multiple life-altering sequelae. The over-arching goals of the principal investigator's research program are to more fully characterize these sequelae and to examine interventions that might improve them. The hypotheses of this particular study are that pulmonary rehabilitation (PR) is one such intervention, and that PR will improve the sequelae of dyspnea and impairments in functional capacity, cognition, mood and anxiety, fatigue, and quality of life (QOL) in patients with IPF.

Key facts

Study ID

NCT01107028

Run by

National Jewish Health

People needed

41

Starts

2010-02-01

Expected to finish

2014-10-01

Last updated by the study team

2020-10-22

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 40 years
• IPF
• Able to walk unassisted for balance
• Able to speak and understand English well enough to complete complex tasks with directions given in English

You may not qualify if…

• Pulmonary fibrosis not due to IPF
• Coexisting comorbid conditions that would make exercise contraindicated

Where it is running

• National Jewish Health — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.